Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-alcoholic Steatohepatitis: From Pathophysiology to Clinical Practice.

TouchREVIEWS in endocrinology·2022
Same author

Recruitment and Retention of Patients for Nonalcoholic Steatohepatitis Clinical Trials.

Gastroenterology clinics of North America·2020
Same author

Enteral Access and Associated Complications.

Gastroenterology clinics of North America·2018
Same author

A nutrition strategy for obese ICU patients with special consideration for the reference of protein.

Clinical nutrition ESPEN·2017
Same author

Mortality among patients who receive or defer gastrostomies.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2013
Same author

Multisociety sedation curriculum for gastrointestinal endoscopy.

Gastroenterology·2012

Related Experiment Videos

Chyle leaks: consensus on management?

Addy Smoke1, Mark H Delegge

  • 1Digestive Disease Center, 25 Courtenay Dr, 7100A, MSC 290, Charleston, SC 29425, USA.

Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition
|October 14, 2008
PubMed
Summary

Chyle leaks, though rare after surgery, pose challenges. Current treatments lack definitive evidence, highlighting the need for further research into optimal management strategies for lymphatic leakage.

Related Experiment Videos

Area of Science:

  • Medical research
  • Surgical complications
  • Gastroenterology

Background:

  • Lymphatic injury can cause chyle leaks in the chest, abdomen, or neck after trauma or surgery.
  • Chyle leaks occur in 1%-4% of surgeries and present significant clinical challenges.
  • Existing treatments include nutritional, surgical, and pharmacological approaches.

Purpose of the Study:

  • To review current treatment strategies for chyle leaks.
  • To identify the lack of definitive evidence supporting specific nutritional therapies.
  • To emphasize the need for prospective studies to establish optimal management.

Main Methods:

  • Literature review of existing studies on chyle leak management.
  • Analysis of nutritional, surgical, and pharmacological treatment options.
  • Identification of clinical consensus and evidence gaps.

Main Results:

  • No definitive evidence supports one nutritional therapy (e.g., bowel rest, parenteral nutrition, low-fat enteral formula) over another for chyle leak treatment.
  • Clinician preferences for specific nutritional interventions are strong but not evidence-based.
  • Optimal management strategies for chyle leaks remain unclear.

Conclusions:

  • The management of chyle leaks lacks a clear consensus, particularly regarding nutritional interventions.
  • Further prospective research is required to determine the most effective treatment strategies.
  • Standardizing the approach to chyle leaks will improve patient outcomes.